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ABSTRACT Erythrocytes are reservoirs of important epoxide-containing lipid signaling molecules, including epoxyeicosatrienoic
acids (EETs). EETs function as vasodilators and anti-inflammatory modulators in the bloodstream. Bioactive EETs are hydro-
lyzed to less active diols (dihydroxyeicosatrienoic acids) by epoxide hydrolases (EHs). The malaria parasite Plasmodium falci-
parum infects host red blood cells (RBCs) and exports hundreds of proteins into the RBC compartment. In this study, we show
that two parasite epoxide hydrolases, P. falciparum epoxide hydrolases 1 (PfEH1) and 2 (PfEH2), both with noncanonical serine
nucleophiles, are exported to the periphery of infected RBCs. PfEH1 and PfEH2 were successfully expressed in Escherichia coli,
and they hydrolyzed physiologically relevant erythrocyte EETs. Mutations in active site residues of PfEH1 ablated the ability of
the enzyme to hydrolyze an epoxide substrate. Overexpression of PfEH1 or PfEH2 in parasite-infected RBCs resulted in a signifi-
cant alteration in the epoxide fatty acids stored in RBC phospholipids. We hypothesize that the parasite disruption of epoxide-
containing signaling lipids leads to perturbed vascular function, creating favorable conditions for binding and sequestration of
infected RBCs to the microvascular endothelium.
IMPORTANCE Themalaria parasite exports hundreds of proteins into the erythrocyte compartment. However, for most of these
proteins, their physiological function is unknown. In this study, we investigate two “hypothetical” proteins of the /-hydrolase
fold family that share sequence similarity with epoxide hydrolases (EHs)—enzymes that destroy bioactive epoxides. Altering EH
expression in parasite-infected erythrocytes resulted in a significant change in the epoxide fatty acids stored in the host cell. We
propose that these EH enzymes may help the parasite to manipulate host blood vessel opening and inflame the vessel walls as
they pass through the circulation system. Understanding how the malaria parasite interacts with its host RBCs will aid in our
ability to combat this deadly disease.
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Asexual replication of the malaria parasite occurs within thehost red blood cell (RBC). After RBC invasion, the parasite
exports several hundred proteins beyond the parasite plasma
membrane and parasitophorous vacuolar membrane (surround-
ing the parasite) into the RBC compartment (1, 2). Exported pro-
teins can alter the flexibility of the RBC cytoskeletal network, re-
sulting in increased cell rigidity compared to uninfected RBCs (3).
Additionally, several exported proteins are displayed as surface
adhesins resulting in cytoadherence of infected erythrocytes to
endothelial cell ligands, including intercellular adhesionmolecule
1 (ICAM-1) (3, 4). This cytoadherence allows infectedRBCs to avoid
premature clearance by the spleen, before the 48-h life cycle of the
parasite is completed. A pentameric signal sequence, called the Plas-
modium export element (PEXEL; also known as the host targeting
signal) (5, 6), is essential for delivery of most exported proteins. On
the basis of identification of this PEXEL sequence, the “exportome”
of Plasmodium falciparum has been predicted (7–9). Additionally,
PEXEL-negative exported proteins have been identified (10), and
these proteins add to the number of parasite proteins exported into
theRBC.Despiteour ability topredict and localize exportedproteins,
their functions, particularly how they interact/interfere with RBC
physiology, remain largely uncharacterized.
RBCs are important regulators of vascular tone. While in cir-
culation, in response to low oxygen content, RBCs release ATP,
which interacts with purinergic P2Y receptors on endothelial cells
to promote nitric oxide (NO) synthesis (11). Subsequent NO re-
lease into the bloodstream inhibits further ATP release from
erythrocytes in a negative-feedback loop. The ATP released from
erythrocytes also acts in an autocrine manner, activating RBC pu-
rinergic P2X7 receptors, which in turn activate cytosolic phospho-
lipase A2 (11). RBCs contain significant pools of epoxyeico-
satrienoic acids (EETs) (12–15), which are epoxide-containing
signaling lipids, released from RBCs in a phospholipase
A-dependent manner (16, 17). EETs interact with smooth muscle
cells, resulting in activation of Ca2-dependent K channels, hy-
perpolarization, and subsequent relaxation/vasodilation (18).
EETs (like NO) are anti-inflammatory (19, 20), inhibiting activa-
tion of the NF-B transcription factor in endothelial cells, pre-





















In healthy individuals, NO and prostacyclins are the main reg-
ulators of vasodilation (18); however, in cardiovascular disease
states (18), or when NO/prostacyclin biosynthesis is inhibited
(21), EETs increase in importance. It is well established that dur-
ingmalaria infection, plasma levels of NO are severely diminished
by multiple mechanisms (22–25). The reduction in the bioavail-
ability of NO contributes to the disruption of basal vasoregulation
and, thereby, to the cerebral and pulmonary hypertension and
reduced blood flow observed in malaria patients (26). When the
concentration of NO is reduced, NF-B-mediated transcription
of adhesin ligands is enhanced, promoting infected-erythrocyte
sequestration in themicrovasculature. Given the decrease in avail-
able NO during malaria, we hypothesized that host EET signaling
may becomemore important duringmalaria infection. If the anti-
inflammatory and vasodilatory properties of the EETs could com-
pensate for the decrease in NO, this would be potentially disad-
vantageous to the parasite (as an “activated” endothelium is
beneficial for cytoadherence).
EETs (20-carbon metabolites derived from arachidonic acid),
and other anti-inflammatory omega-3 and omega-6 epoxygen-
ated fatty acids, including epoxyoctadecenoic acids (EpOMEs; 18
carbon equivalents derived from linoleic acid) are metabolized by
epoxide hydrolases (EHs), converting the active epoxide fatty ac-
ids into much less active diols (27, 28). EHs are / hydrolases
that function both in the detoxification of exogenous epoxides
(including toxins/drug metabolites) and in the regulation of lipid
signaling epoxides.
P. falciparum carries genes that encode four /-hydrolases
containing PEXEL motifs (5, 8), and all four /-hydrolases are
present only in the Laverania subgenus (P. falciparum and Plas-
modium reichenowi), with no identifiable syntenic orthologues in
other Plasmodium species (29). In this study, we demonstrate that
all four /-hydrolases are exported. Two of the /-hydrolases
share sequence homology with EHs, and our results suggest that,
despite having atypical catalytic serine residues, they are capable of
hydrolyzing bioactive erythrocyte epoxides to less active 1,2-diols.
These enzymes are able to deplete the host erythrocyte of vasoac-
tive epoxides and therefore may play an important role in the
vascular biology of malaria infection.
RESULTS
Four PEXEL-containing /-hydrolases are grouped in two
families with different predicted activities. P. falciparum carries
genes that encode four /-hydrolases containing PEXEL motifs,
grouped into two families: /-hydrolase group A (PF3D7_
0301300 and PF3D7_1401300) and /-hydrolase group B
(PF3D7_1001400 and PF3D7_1001600) (5, 8). Using a local pair-
wise alignment algorithm, the two members of /-hydrolase
family A are 41.4% identical (61.4% similar), and the two mem-
bers of /-hydrolase family B are 53.3% identical (72.5% simi-
lar). However, comparisons between family A and B protein se-
quences reveal less than ~19% identity between the two families.
/-Hydrolase fold proteins are a diverse superfamily of en-
zymes, and despite low sequence similarity at the amino acid level,
some distinguishing motifs can aid in the classification of various
/-hydrolase families. To gain insight into the potential func-
tions of the exported /-hydrolases, a PSI-BLAST pseudo-
multiple-sequence alignment (comparing the protein of interest
to the nonredundant protein data bank) was generated using
the online Phyre2 server (30). The top five, unique, non-
Apicomplexan hits (with lowest E values) for the P. falciparum
/-hydrolase family A members have the highest similarity to
proteins of the epoxide hydrolase family (Interpro IPRO00639;
hereafter we refer to PF3D7_0301300 as PfEH1 [P. falciparum
epoxide hydrolase 1] and PF3D7_1401300 as PfEH2), whereas
/-hydrolase family B members had the highest similarity to the
lysophospholipase/serine aminopeptidase family (Interpro
IPRO22742; hereafter we refer to PF3D7_1001400 as PfXL1 [for
P. falciparum exported lipase 1] and PF3D7_1001600 as PfXL2)
(see Table S1 in the supplemental material).
PfEH1 and PfEH2 are exported from the parasite and are
tethered to the erythrocyte cytoskeleton. To investigate the ex-
port of the four PEXEL-containing /-hydrolases, we generated
parasites ectopically expressing a C-terminal green fluorescent
protein (GFP) fusion of each /-hydrolase (see Fig. S1A and S1B
in the supplementalmaterial). For the two/-hydrolase familyA
members, fluorescence was observed at the periphery of the in-
fected erythrocyte and within the parasite (Fig. 1A and B). In con-
trast, for the two family B members, fluorescence was diffuse
throughout the cytosol of the infected RBC (Fig. 1C and D).
We chose to focus our study on the two putative epoxide hy-
drolases. We generated parasite integrants expressing the putative
EH of interest fused to GFP, under control of the endogenous
promoter (see Fig. S1C to S1F in the supplemental material). In
asexual parasites, anti-GFP antibody detected PfEH1 and PfEH2
at the periphery of the infected erythrocyte andwithin the parasite
(Fig. 2A andB). The fluorescence at the periphery colocalizedwith
ring-exported surface antigen (RESA) (PF3D7_0102200), an ex-
ported protein that interacts with host spectrin at the RBC cyto-
skeleton (31). Expression from the endogenous locuswas low, and
by Western blotting, the endogenously tagged PfEH1-GFP or
PfEH2-GFP parasites had fusion protein levels that were ~17 
5-fold (n 4) and ~6 2-fold (n 4) lower than in the overex-
pression parasites used in Fig. 1 (Fig. 2C and D).
The PfEH1/2-GFP parasites were used to detect potential in-
teracting partners, which were isolated by pulldown using anti-
GFP antibodies and identified using mass spectrometry (see Ta-
ble S2 in the supplemental material). An enrichment of peptides
was observed for / spectrin. A similar enrichment for spectrin
was not observed in the 3D7 parent, or when PfXL-GFP proteins
were used as bait, suggesting that the immunoprecipitation pro-
cedure was not nonspecifically pulling down cytoskeletal con-
tents. Chaperones commonly isolated as contaminants (e.g.,
HSP70) were pulled down equally in all samples, while compo-
nents of the export machinery (e.g., HSP101) were immunopre-
cipitated only in the /-hydrolase-GFP parasites.
The interaction of the PfEHs with spectrin was confirmed by
Western blotting, whereby the GFP-tagged PfEH1/2 were pulled
down with anti-GFP antibodies, and the resulting fraction was
probed with an antispectrin antibody. Spectrin was present in the
immunoprecipitate from GFP-tagged PfEH1/2 lines, but not in
the 3D7 parent (Fig. 2E). Consistent with a cytoskeletal interac-
tion, PfEH1 and PfEH2 were both present in the carbonate frac-
tion of a differential solubility assay (Fig. 2F), along with spectrin.
In both the immunoprecipitation and fractionation experiments,
the size of the GFP-tagged PfEH1/2 protein corresponded to the
processed form, after cleavage at the PEXEL motif. The results of
the localization and fractionation experiments indicate that
PfEH1 and PfEH2 are in close proximity to the erythrocyte cyto-
skeleton and membrane phospholipids.
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Spectrin has previously been identified as a major hub for lo-
calization of exported proteins (32), including P. falciparum
erythrocyte membrane protein 1 (PfEMP1) (33), PfEMP3 (34,
35), RESA (31), and knob-associated histidine-rich protein
(KAHRP) (36). Spectrin is known to interact with other RBC cy-
toskeleton members, and also lipids, via charged regions (37–39).
We examined the amino acid content of the PfEH proteins and
identified a highly charged region in the N terminus of themature
protein dominated by charged Lys and Glu residues in PfEH1 and
Asp (and neutral Asn) residues in PfEH2 (Fig. 3A and B). We
hypothesized that this charged region (CR) may be important for
cytoskeletal tethering, so for PfEH1, this region was truncated to
assess the role of the CR in PfEH1 localization (Fig. 3C). Each
construct contains the hydrophobic signal peptide and PEXEL
sequence fused to the protein domains of interest, followed by a
10-amino-acid linker sequence (PRPGAAHYAA; used previously
[40]), and the GFP reporter. When the 64-amino-acid CR was
truncated by 22 and 42 amino acids, the reporter was still seen to
be exported to the RBC periphery (by both microscopy and teta-
nolysin O fractionation; Fig. 3C and D), similar to what has been
seen with full-length reporter (Fig. 1A and 2D). However, com-
plete truncation of the CR abolished export (Fig. 3C and D), sug-
gesting that the CR contains export-relevant information. Fusing
the signal peptide/PEXEL directly to the GFP reporter did not
permit export (although as seen previously, the linker sequence
may not be sufficient to spatially separate the PEXEL and tightly
folded GFP [41–43]). Additionally, when the /-hydrolase do-
main was truncated, the CR region was sufficient to promote ex-
port of the reporter construct (Fig. 3C). However, the protein was
no longer tethered at the RBC periphery and was found in the
tetanolysin O-soluble fraction (Fig. 3D). This indicates that the
/-hydrolase domain contains information relevant for the teth-
ering of PfEH1 to the cytoskeleton.
PfEH1 and PfEH2 hydrolyze epoxides, including physiolog-
ically relevant signaling lipids. EHs are distinguished from other
/-hydrolase fold proteins on the basis of several key motifs (44,
45)—anHGXPmotif (part of the oxyanion hole), two tyrosines in
the cap domain (functioning in substrate recognition and posi-
tioning for the ring-opening reaction), and a GXSmXS/T motif
(unknown function) (46). EHs also have a well-studied catalytic
triad (nucleophile-acid-base) (44, 45). Amino acid alignments,
comparing the sequences of PfEH1/2, PfXL1/2, and the four hu-
man EHs, revealed that for PfEH1 and PfEH2, the oxyanion hole
motif and GXSmXS/T motif are mostly conserved, and the ring-
opening tyrosines (potentially Y316/Y334 in PfEH1 and Y318/
Y343 in PfEH2) and catalytic triad are easily identifiable (see
Fig. S2 in the supplemental material). A major difference is that
PfEH1 and PfEH2 contain a serine (S240 in PfEH1 and S249 in
PfEH2) in the position where other EHs contain a catalytic aspar-
tate (44, 45).
To inform recombinant protein experiments, a model of
PfEH1 was generated. The cap domain and core /-hydrolase
fold domains are identifiable, and the active site residues are clus-
tered near several putative ring-opening tyrosines (Fig. 4A). Ro-
bust expression of N-terminal poly(His)-tagged PfEH1 and
PfEH2, and of several PfEH1mutants, was achieved in E. coli. The
activity of the recombinant enzymes was investigated using the
EH reporter substrate epoxy fluor 7 (EF7 [47]). Purified PfEH1
hydrolyzed EF7; however, PfEH2 had very low activity against this
substrate (Fig. 4B). PfEH1 activity was significantly diminished
when mutations were made in the active site (S240A, D367A, and
H395A), but not when a serine distal to the active site (in the cap
FIG 1 Four /-hydrolases are exported into the erythrocyte compartment. Immunofluorescence assay (IFA) of trophozoite/early schizont-stage parasites
overexpressing GFP-tagged /-hydrolases. Parasites were fixed with paraformaldehyde/glutaraldehyde and stained with anti-GFP (green). The nuclei were
stained with 4=,6=-diamidino-2-phenylindole (DAPI) (blue). (A) PfEH1-GFP, (B) PfEH2-GFP, (C) PfXL1-GFP, and (D) PfXL2-GFP. Expression was under
control of the constitutive HSP86 promoter (see Fig. S1A and S1B in the supplemental material). The images are representative of at least three independent
experiments. Bars 5 m. DIC, differential interference contrast.
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domain) was mutated (S207A) (Fig. 4B). We attempted to make
the PfEH1 active site more closely resemble the active site of hu-
man EHs bymutating the catalytic serine to an aspartate (S240D).
However, thismutation also significantly reduced the ability of the
recombinant enzyme to hydrolyze the EF7 substrate (Fig. 4B).
C-terminal poly(His)-tagged PfEH1 and PfEH2 were also ex-
pressed and purified, and these enzymes displayed activity that
was not significantly different from the activity of the N-
terminally tagged proteins.
To examine the ability of the recombinant enzyme to hydro-
lyze physiological substrates, we incubated the recombinant
PfEH1 or PfEH2 with 14(15)-EET or 11(12)-EET and used an
enzyme-linked immunosorbent assay (ELISA) to detect forma-
tion of the respective diol products 14(15)-dihydroxyeico-
satrienoic acid [14(15)DHET] or 11(12)-DHET. Both recombi-
nant PfEH1 and PfEH2 enzymes increased the formation of the
diol product above levels generated by spontaneous hydrolysis
(Fig. 4C and D).
PfEH1 and PfEH2 can be disrupted in vitro. To assess the in
vitro importance of PfEH1 and PfEH2, parasite lines were gener-
ated in which either individual locus was disrupted by double-
crossover recombination, with insertion of the yeast dihydrooro-
tate dehydrogenase (yDHODH) selection cassette (strategy in
Fig. S3A to S3D in the supplemental material). Neither single-
knockout parasite line displayed any obvious morphological
changes or significant alteration of growth rate compared to the
3D7 parental line (Fig. S3E). A double-knockout line was created
by knocking out PfEH1 and -2 sequentially using orthogonal drug
FIG 2 PfEH1 and PfEH2 interact with the erythrocyte cytoskeleton. IFA of paraformaldehyde/glutaraldehyde-fixed, trophozoite/early schizont-stage parasites
expressing PfEH1-GFP (A) or PfEH2-GFP (B) under control of the respective endogenous promoter. The GFP-expressing parasites were costained with
anti-RESA (red). The nuclei were stained with DAPI (blue). Bars 5 m. DIC, differential interference contrast. (C and D) Western blots of PfEH expression
in trophozoite-stage parasites. PfEH proteins are not detected in 3D7 parent parasites, barely detected when GFP tagged at the endogenous locus (endo), and
highly expressed in the episomal overexpression (EOE) lines. P. falciparum haloacid dehalogenase 1 (PfHAD1) is used as a loading control. -GFP, anti-GFP
antibody. (E) Immunoprecipitation (IP) of RBCs infected with the 3D7 parent line, PfEH1-GFP or PfEH2-GFP (EOE lines). Complexes were isolated with
anti-GFP antibodies, and the final eluate was probed with anti-GFP antibody to confirm pulldown of the PfEH proteins and with human antispectrin antibody.
The positions of molecular mass markers (in kilodaltons) are shown to the left of the blots in panels C to E. (F) Sequential fractionation of the 3D7 parent line,
PfEH1-GFP, or PfEH2-GFP (EOE lines). TheRBCplasmamembranewas permeabilizedwith tetanolysinO (TetO). The total (T) fraction, pellet (P) fraction, and
supernatant (SN) fractions are shown in the three leftmost portion of the blots. The pellet fraction was then subjected, sequentially, to hypotonic lysis (Tris HCl)
to release soluble parasitophorous vacuole (PV)/parasite/Maurer’s cleft contents, carbonate (Carb.) to release membrane fraction-associated contents, Triton
X-100 (TX100) to release membrane contents, and the final pellet was solubilized in Triton X-114 (TX114)/SDS. P. falciparum serine-rich protein (PfSERP) is a
soluble parasitophorous vacuole integrity marker, and PfHAD1 is a soluble parasite integrity marker.
Spillman et al.

















FIG 3 The charged region (CR) of PfEH1 is required for export, and the/-hydrolase region is required for cytoskeletal tethering. (A) The amino acid composition
of the first 66 residues of mature PfEH1 (EH1CR) was compared to the last 315 residues (EH1AB) using PEPSTATS. The Dayhoff statistic compares the relative
occurrence of the amino acid per 1,000 residues to the theoretical Dayhoff statistic for protein composition. A value of 1.0 represents typical frequency. (B) The amino
acid composition of the first 49 residues ofmature PfEH2 (EH2CR)was compared to the last 333 residues (EH2AB). (C) Schematic representing the PfEH1 truncation
(Trunc) constructs. Each construct contains theN-terminal signal sequence and PEXELmotif, as well as a linker region (L) before the reporter GFP. SP, signal peptide.
ABH, /-hydrolase. (Right) Images from IFA of paraformaldehyde/glutaraldehyde-fixed, trophozoite/early schizont-stage parasites expressing the truncated PfEH1
under control of the HSP86 promoter. The nuclei were stained with DAPI (blue). Bars  5 m. DIC, differential interference contrast. (D) Fractionation of the
PfEH1-GFP truncation lines with tetanolysinO (TetO). The top blot is probedwith both anti-GFP and anti-PfHAD1, a soluble parasite integritymarker. P. falciparum
histidine-rich protein II (PfHRPII) is a soluble exported protein, and PfSERP is a soluble parasitophorous vacuole integrity marker. Lanes: T, total; P, pellet; SN,
supernatant. The blots are representative of two or three independent fractionations for each cell line.
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selection cassettes. Southern blotting confirmed the successful
generation of PfEH1/2 double-knockout clones (Fig. 5A and B).
As was the case for the single knockouts, the double knockout also
had no observable morphological changes or alteration in growth
rate (Fig. 5C). PfEH1 and -2 do not appear to be required for
growth in culture.
Previously reported expression profiling revealed that field iso-
lates (with minimal in vitro culturing) have increased expression
levels of PfEH1 and PfEH2 genes (5- to 10-fold; data from
genome-wide RNA analysis in Vignali et al. [48]) (Fig. 5D). This
suggested that expression of PfEH1/2may be beneficial in vivo.We
examined three field isolates that had been adapted to in vitro
culture through cryopreservation/thawing three times before
analysis (49, 50). After a limited number of additional cryopreser-
vation/thawing steps in our laboratory, we isolated RNA from
these parasites and examined the relative expression of PfEH1 and
PfEH2 in these culture-adapted field isolates compared to two
3D7 laboratory lines. Quantitative reverse transcription-PCR
(RT-PCR) demonstrated that there was no significant difference
in expression of either PfEH gene in these field lines adapted to in
vitro culture (Fig. 5E). These results suggest that the ectopic over-
expression constructs of PfEH1/2 (Fig. 1A and B) may be more
representative of in vivo expression levels (i.e., high expression),
whereas laboratory-adapted lines have reduced requirement to
express PfEH1/2 (i.e., low expression).
Overexpression of PfEH1 or PfEH2 results in a reduction in
erythrocyte epoxide signaling lipids. To explore the effect of al-
tering PfEH1 or PfEH2 expression on the composition of eryth-
rocyte epoxide signaling lipids, fatty acid preparations were iso-
lated from the phospholipid fraction of erythrocytes infected with
the PfEH1/2 double-knockout clones (from Fig. 5) or the PfEH1-
or PfEH2-overexpressing lines (from Fig. 1). These lipid prepara-
tions were analyzed using a targeted liquid chromatography cou-
pled to tandem mass spectrometry (LC/MS/MS) approach to
FIG 4 Activity of recombinantly expressed PfEH1 and PfEH2 in in vitro epoxide hydrolysis assays and identification of key catalytic residues in PfEH1. (A)
Model of PfEH1 (created in Robetta [88], using the structures of Pseudomonas putida /-hydrolase [PDB accession no. 1ZOI] and human soluble epoxide
hydrolase [HsEH2] [PDB accession no. 1S8O]). The variable cap domain and conserved /-hydrolase domains are annotated, and key residues are highlighted
in contrasting color and shown in stick format. (B) PfEH1, PfEH2, and several PfEH1 mutants were expressed in E. coli BL21(DE3). The PfEH proteins were
purified by affinity and size exclusion chromatography (two to nine independent inductions/purifications for each condition). Measurement of the fluorescent
product (6-methoxy-2-napthaldehyde) generated after hydrolysis of the substrate epoxy fluor 7 (EF7) (structure shown above the graph). All proteins were
N-terminally His tagged, except for PfEH1_C and PfEH2_C, which are C-terminally His tagged. Values are means plus SEMs (error bars). Values that are
statistically significantly different from the value for PfEH1 (P 0.05 by one-way ANOVA with Tukey’s posttest) are indicated with an asterisk. Values that are
not statistically significantly different (n.s.) are also indicated by bars. (C and D) Recombinant PfEH1 and PfEH2 proteins were incubated with 11(12)-EET
(structure shown above the graph in panel C) or 14(15)-EET (structure shown above the graph in panel D). Production of the respective diol wasmeasured using
ELISA (n  2 to 4, using protein purified from two independent inductions). Values that are statistically significantly different from background (Bkgd)
hydrolysis by unpaired t test are indicated as follows: *, P 0.05; #, P 0.08. For the 11(12)-EET substrate, the increase in hydrolysis was significant for PfEH1
(P 0.027; n 4) but did not reach significance for PfEH2 (P 0.064; n 4). For the 14(15)-EET substrate, the increase in hydrolysis was significant for PfEH2
(P 0.043; n 3) but did not reach significance for PfEH2 (P 0.077; n 3).
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measure three EET regioisomers [14(15)-EET, 11(12)-EET, and
8(9)-EET] and two EpOME regioisomers [12(13)-EpOME and
9(10)-EpOME]. It has been previously reported that the concen-
tration of EETs in erythrocytes varies significantly between indi-
vidual blood donors (by 2- to 3-fold) (14). We also observed a 2-
to 3-fold variation in RBC epoxy fatty acid content between blood
donors used over the course of this study (Fig. 6A). Therefore, it
was essential to pair all analyses and use blood from the same
donor/donor pool for culture of a parasite line within an experi-
ment. When RBCs were infected with the 3D7 parasite line, there
were no significant differences in any of the five analytesmeasured
compared to the control uninfected RBCs (Fig. 6B and C). There
were also no significant differences in epoxy fatty acid content
comparing infection with the 3D7 parent to infection with the
PfEH1/2 double-knockout clones (Fig. 6B and C). However, in
the PfEH1- or PfEH2-overexpressing lines, compared to the 3D7
parent line, there was a substantial reduction of several epoxy
signaling lipids. These results are consistent with PfEH1 and
PfEH2 altering the concentration of epoxy signaling lipids within
the infected erythrocytes.
DISCUSSION
The physiological functions of the several hundred P. falciparum
proteins exported into the host cell remain poorly characterized.
In this study, we show that four /-hydrolases are exported into
the RBC and that two of these, PfEH1 and PfEH2, have epoxide
hydrolase activity and are capable of hydrolyzing bioactive RBC
lipid epoxides to less active diols. We propose that the malaria
parasite can reduce lipid epoxide signaling of the host RBC, a
disruption that may lead to perturbed vascular signaling and in-
flammation.
In circulating RBCs, stimuli, such as shear stress or stimulation
of the purinergic P2X7 receptors by ATP, activate phospholipase
A2, which releases EETs from their esterified form in membrane
phospholipids into a soluble free fatty acid form in the cytosol (16,
17). Following de-esterification, the soluble EETs are then re-
FIG 5 PfEH1 and PfEH2 can be knocked out in cultured parasites. (A and B) Southern blots of digested genomic DNA from the parent 3D7 line, vector, and
double-knockout clones. Analysis at both the PfEH1 (A) and PfEH2 (B) loci demonstrate the simultaneous disruption of both genes in clones 3G and 11C, but
not in clone 1E. The black arrows to the right of the blots indicate the expected size for correct integration, and the asterisk indicates a band of unknown origin.
In panel B, the pUF-TK_PfEH2 vector [Vector (#)] was used instead of pCC1_PfEH2 (called pABH-DKO in reference 89). The schematic representations of the
integration events are outlined in Fig. S2 in the supplementalmaterial. (C)Growth of the 3D7parent line and the twodouble-knockout (DKO) clones over 4 days.
No differences were observed in growth between these three cell lines, with this graph representative of data from three independent experiments. The doubling
times are 1.14  0.12 days for the 3D7 parent, 1.16  0.10 days for double-knockout clone 3G, and 1.26  0.12 days for double-knockout clone 11C (not
significantly different [P 0.53] using pairwise t tests; n 3 for each). The smooth curve is the fitted exponential growth equation. (D)Transcript levels of PfEH1
and PfEH2 in unsynchronized 3D7 laboratory strain compared to field isolates from malaria-infected pregnant women or malaria-infected children. The data
shownwere taken fromVignali et al. (48). (E)Normalized expression of PfEH1 or PfEH2 in two laboratory strains (Saint Louis STL-3D7 orMRA-3D7) and three
laboratory-adapted field isolates from Cambodia (MRA-1237, MRA-1238, and MRA-1241). Quantitative RT-PCR was performed using probes against PfEH1
and PfEH2, with actin as a reference gene. Values are normalized to the average expression in STL-3D7 and MRA-3D7. Data were calculated from three
independent RNA preparations (means plus SEMs [error bars]) and are not significantly different using a two-way ANOVA (P 0.05).
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leased from the RBCs in a process requiring the cystic fibrosis
transmembrane regulator (CFTR), pannexin-1, and the voltage-
dependent anion channel (VDAC) (17, 51). Infection with P. fal-
ciparum is known to activate several RBC ATP release pathways,
including VDAC (52–54). Therefore, it is possible that EET de-
esterification and release is activated during P. falciparum infec-
tion. The observed localization of PfEH1 andPfEH2 at the periph-
ery of the infected RBC would facilitate the rapid metabolism of
released epoxy fatty acids.
Aside from proximity to substrate, the functional significance
of the observed interaction of the PfEHs with the RBC cytoskele-
ton is unknown. Further work is necessary to demonstrate a direct
interaction between the PfEHs and spectrin (or another cytoskel-
etal component) and to investigate whether the PfEHs interact
with other malarial proteins at the cytoskeleton. Our analyses of
truncation mutants of PfEH1 suggested that the /-hydrolase
domain, and not the highly charged mature N-terminal region, is
essential for the cytoskeletal interaction. Other exported proteins,
where there is direct evidence for their interaction with the cyto-
skeleton, also contain charged regions or charged repeats, includ-
ing KAHRP (32, 33, 36) and lysine-rich membrane-associated
PHISTb protein (LYMP) (55, 56); however, the function of their
charged regions is unstudied. The highly charged N-terminal re-
gion in PfEH1 was necessary to facilitate export. Three differ-
ent charged PfEH1 mature N termini (full-length/ABHTrunc,
CRTrunc1, and CRTrunc2) permitted export into the RBC, but
the two truncations without the charged N termini (CRTrunc3
and EH1Trunc) did not. Charge differences between the N and C
termini of exported proteins were previously proposed to contrib-
ute to the export process (57, 58); however, it was subsequently
shown that scrambling the N-terminal charged regions reduces
export (42), suggesting that the sequence was also a driving factor.
It is also possible that for the two truncations that were not ex-
ported, there was a steric block along the secretory pathway. The
requirement to separate the PEXEL motif from the tightly folded
GFP core, in a sequence-independentmanner, has been described
(41), with the hypothesis being that if the N-terminal signal is too
short, it cannot be efficiently recognized and/or unfolded by chap-
erones/export machinery in the parasitophorous vacuole. It is
possible that the export signal is too tightly associated with GFP
(for EH1Trunc) or with the structured /-hydrolase domain
(for CRTrunc3) to be recognized for successful export. Further
dissection of the PfEH1 (and PfEH2) protein is necessary to clarify
the requirements for export and the requirements for cytoskeletal
interaction in more detail.
In this study, we demonstrate that PfEHs were able to hydro-
FIG 6 LC/MS/MS measurement of epoxide-containing fatty acids in phospholipid preparations from parasitized RBCs. Internal standards 5(6)-EET-d11,
8(9)-EET-d11, 11(12)-EET-d11, 14(15)-EET-d11, and 9(10)-EpOME-d4 were added to each sample, phospholipids were extracted with 2:1 CHCl3CH3OHplus
0.1 mM triphenylphosphine, and fatty acids were released using phospholipase A2. Four-point calibration curves were generated using the deuterated standards
to quantify the epoxide analytes. (A) Sumof 8(9)-EET, 11(12)-EET, 14(15)-EET, 9(10)-EpOME, and 12(13)-EpOME in uninfected RBCs (uRBC). Samples were
run twice, and the error bars depict range/2. (B and C) 9(10)-EpOME and 12(13)-EpOME (B) and 8(9)-EET, 11(12)-EET, and 14(15)-EET (C) concentrations
in phospholipids of uninfected RBCs (U) and RBCs infected with 3D7 parent (I), PfEH1-GFP (PfEH1eoe), PfEH2-GFP (PfEH2eoe), and PfEH1 PfEH2
double-knockout (DKO) clones 3G and 11C. The values shown are calculated from 3 to 9 independent phospholipid preparations per condition (mean SEM).
Values that are statistically significantly different from the value for infected RBCs (P 0.05 by paired t tests) are indicated by an asterisk. For PfEH1, there was
a significant reduction in 12(13)-EpOME (P 0.049; n 4), 9(10)-EpOME (P 0.043; n 4), 11(12)-EET (P 0.0154; n 4), and 8(9)-EET (P 0.034;
n 4), while for PfEH2, several compounds showed reductions, but the decrease reached statistical significance only for the 9(10)-EpOME analyte (P
0.028; n  4).
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lyze epoxides in in vitro experiments with recombinantly ex-
pressed PfEHs and also in parasite-infected RBCs. In the assays
reported here, PfEH1 and PfEH2 behaved similarly (the exception
being that PfEH2 did not hydrolyze the EF7 fluorescent reporter
substrate, though EHswith poor activity against nonphysiological
fluorescent reporters but higher activity against endogenous sub-
strates have been reported [59]). If the localization and ability to
hydrolyze EETs/EpOMEs are similar, then it is unclear why P. fal-
ciparum would express two EHs. One possibility is that the two
enzymes are not redundant, as they have different substrate selec-
tivities. Alternatively, they may be important at different stages of
the intraerythrocytic life cycle. Consistent with this hypothesis,
previous studies indicated that PfEH2 may be upregulated in the
gametocyte (sexual) stage (5, 60). PfEHsmay also be important in
the parasite mosquito stages as EETs and EpOMEs are taken up in
themosquito bloodmeal.Mosquito EHs can reduce EET/EpOME
levels (61, 62), and modulating EH activity alters the mosquito
immune response, which may alter parasite viability (63). Both
PfEH1 and PfEH2 are upregulated in field isolates (48) (Fig. 5D);
therefore, the PfEH-overexpressing lines created in this studymay
be more physiologically relevant to study EH function compared
to laboratory-adapted lines, such as 3D7, which expresses very low
levels of EH enzymes and behaved like our PfEH1 double-
knockout line.
One challenge in studying epoxide-containing signaling lipids
is the instability of thesemetabolites. The level of epoxy fatty acids
in our cultured RBCs (~10 ng EETs/109 RBCs) was lower than
previously reported for “fresh” RBCs (~33 ng EETs/109 RBCs)
(14). Goulitquer and colleagues reported EET levels to be quite
unstable, with a rapid loss of approximately 20 to 30% in the first
hour after the blood draw, though the decrease is slower at 4°C
(14). Our parasites are cultured at 37°C for several days, likely
leading to the decreased level of the epoxy fatty acids reported
here. Examination of epoxy fatty acid profiles in freshly drawn
blood from healthy individuals compared to patients infected
with P. falciparum would provide further evidence of the signifi-
cance of PfEHs in altering RBC physiology. A previous report
examined the vasoactivity of RBCs from P. falciparum malaria-
infected patients in Benin and found increased contractile re-
sponses in the malaria-infected RBCs compared to uninfected
samples (64). This result is consistent with a decrease in vasodila-
tory signals (e.g., EETs) upon malaria infection. Interestingly, the
four /-hydrolases are part of a “greatly expanded exportome”
found in P. falciparum (and P. reichenowi) (8). These species-
specific exported proteins are thought to be involved in the traf-
ficking and display of the virulence ligand PfEMP1 (8). It is pos-
sible that the PfEHs contribute to the vascular inflammation and
display of PfEMP1-compatible adhesins, although this hypothesis
requires experimental investigation.
P. falciparum is not the only pathogen to use an EH to alter host
function. EH activity has been extensively studied in Pseudomonas
aeruginosa, a bacterium that causes opportunistic pulmonary in-
fections, particularly in some cystic fibrosis cases. P. aeruginosa
secretes the “CFTR inhibitory factor,” or Cif EH (65), and the Cif
EH enters into the airway epithelial cells. Although Cif has classi-
cal EH activity (66, 67), it also inhibits CFTR endocytic recycling
(66, 68), leading to a decrease in apical CFTR levels, exacerbating
cystic fibrosis symptoms. The Cif EH has a noncanonical active
site, including having a glycine instead of a proline in the HGxP
motif (69). Differences in reaction mechanism (compared to the
well-studied human soluble EH [sEH]) may be necessary to facil-
itate the non-EH Cif activities. The PfEHs also have a noncanoni-
cal active site, as they lack the aspartate nucleophile found in char-
acterized EHs. It has previously been hypothesized that an EH
using a serine nucleophile would result in an “overly stable reac-
tion intermediate” (70); however, the nucleophile alone is not the
sole residue driving EH activity (71). Solving the crystal structure
of PfEH1 or PfEH2 would allow an examination of the active site
features. The full range of PfEH substrates and functions requires
further characterization.
It is possible that the PfEHs, like Cif, may have other non-EH
activities and that these activities may require a serine nucleophile
(a residue facilitating an incredibly diverse array of at least 17
/-hydrolase enzymatic activities [72]). Consistent with this, it
was recently described that PfEH2 also possesses an S33 class pro-
line aminopeptidase activity (73). The peptidase activity of PfEH2
is low (reported Km of 403 M and kcat/Km of ~28 M1 s1 [73])
compared to other characterized proline aminopeptidases (74,
75). The physiological substrate(s) and relevance of this activity
are yet to be determined. Epoxide hydrolases are common non-
peptidase homologues of the S33 class peptidases (76, 77), due to
the broad hidden Markov matrices used to identify peptidase
members (78). Functional promiscuity in the /-hydrolase fam-
ily has been reported (79), and investigation into whether the
PfEHs possess multiple activities requires further study. Interest-
ingly, in the study on the proline aminopeptidase of PfEH2, the
infected RBC (iRBC) membrane of the PfEH2 knockout parasites
was more elastic than that of the parent parasites (73), which may
reflect a change in the phospholipid composition of these para-
sites.
Pharmacological inhibition of PfEHs in vivomerits further in-
vestigation. Promoting a “quiescent” endothelium and normal
vasoreactivity would be disadvantageous to the parasite, as fewer
endothelial adhesins displayed would result in less cytoadherence
and increased splenic clearance of parasitized RBCs. Multiple EH
inhibitors are in development (67, 80, 81), with several currently
in clinical trials (ClinicalTrials.gov identifier [ID] NCT00847899,
NCT01762774, and NCT02006537). If epoxy signaling lipids are
important for reducingP. falciparum virulence in vivo, there is also
a possibility that these inhibitorsmay be repurposed as antimalar-
ials. Aside from modulating the host EH enzymes, it may also be
possible to directly target the PfEHs, and work in this area is on-
going. Understanding the regulation of RBC epoxide-containing
signaling lipids by parasite EHs will pave the way for the identifi-
cation and validation of new drug targets within this pathway.
MATERIALS AND METHODS
See supplemental material for full details.
P. falciparum culture. P. falciparum line 3D7 was cultured at 2%
hematocrit in O erythrocytes in RPMI 1640 supplemented with
0.5% (wt/vol) Albumax II (40). Cultures were grown statically in 5% O2,
5% CO2, and 90% N2. As required, cultures were synchronized with 5%
(wt/vol) sorbitol (82). Parasites generated in this study includeC-terminal
GFP-tagged PfEH1 or PfEH2 (expression under control of the endoge-
nous or heat shock protein 86 [HSP86] promoters; see Fig. S1 in the
supplemental material), C-terminal GFP-tagged PfXL1 or PfXL2 (under
control of the HSP86 promoter; Fig. S1), and single- or double-knockout
parasites of PfEH1 and PfEH2 (Fig. S3). Infected erythrocytes (mid-stage
trophozoites) were enriched to95%parasitemia using LD columns on a
QuadroMACS separator.
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Immunofluorescence assay, cell fractionation, immunoprecipita-
tion, mass spectrometry, and Western blotting. Indirect immunofluo-
rescence assay (IFA) (83, 84) and sequential permeabilization of enriched,
infected erythrocyte compartments (42) was performed as previously de-
scribed. For immunoprecipitation, parasite lysates were incubated with
protein A Dynabeads (Molecular Probes) and nutated with rabbit poly-
clonal anti-GFP (ab6556; Abcam) (2 to 5 g) for 16 h (4°C).
Epoxide hydrolase activity assays. Epoxy fluor 7 (EF7), EETs, and
EpOMEs were from Cayman Chemicals. Fluorescence/absorbance was
monitored using an EnVision Multilabel plate reader (PerkinElmer). EH
activity was measured using the EF7 substrate (47) in a 200-l reaction
mixture containing 5 M EF7 and 10-g recombinant enzyme in
phosphate-buffered saline (PBS) (expressed in E. coli as previously de-
scribed [85]). Diol formation (measuring 6-methoxy-2-naphthaldehyde
production) was quantified by measuring fluorescence (excitation at
340 nmand emission at 450 nm). Calculation of the initial (linear) rates of
substrate hydrolysis was determined usingGraphPadPrism software (v5).
EH activity against the 11(12)-EET and 14(15)-EET regioisomers was
measured using the 11(12)- or 14(15)-DHET ELISA kit, according to the
manufacturer’s protocol (Detroit R&D), with some modifications. Reac-
tion mixtures (100l) contained 6 or 12MEET and 100g EH recom-
binant enzyme in PBS andwere incubated at 37°C for 1.5 h. Sample buffer
(900 l) was added to the reaction mixture, and 100 l was loaded onto
the ELISA wells in duplicate. Absorbance was measured at 450 nm.
Gene expression by quantitative reverse transcription-PCR (qRT-
PCR). Strains used were P. falciparum (“Saint Louis” 3D7 [86] or “MRA-
102” 3D7 [obtained through BEI Resources Repository, NIAID, NIH:
contributed by D. J. Carucci/A. Craig]) and Cambodian field isolates (49,
50) (MRA-1237, -1238, and -1241 [strains IPC 3663, 4884, and 4912,
respectively, obtained through BEI Resources Repository, NIAID, NIH:
contributed byD.Menard]). Tightly synchronized parasites were saponin
isolated (0.05% saponin in PBS; 5 min, room temperature) and RNA was
isolated using the RNeasyminikit (Qiagen) with on-columnDNase treat-
ment (15 min, room temperature). One-step RT-PCR was performed
using the TaqMan fast virus one-step RT-PCRmaster mix (Life Technol-
ogies) using an Applied Biosystems 7500 Fast real-time PCR system.
Primer sets and probes were designed (IDT PrimeTime quantitative PCR
[qPCR] assay) for PfEH1, PfEH2, and actin (PF3D7_1246200) (see Ta-
ble S1 in the supplemental material). The relative expression levels of
PfEH1 and PfEH2 were calculated using the comparative threshold cycle
(CT) method (87) using actin as a reference control gene. Normalized
gene expression was calculated as 2CT where CT CT (actin) CT
(PfEH) where CT (actin) is the threshold cycle of actin and CTCT
(average STL/MRA 3D7) CT (Cambodian isolate).
Analysis of EET and EpOMEmetabolites by LC/MS/MS. Lipid mass
spectrometry was performed at the Metabolomics Facility at Washington
University (P30 DK020579). Enriched (95% parasitemia, Quadro-
MACS), trophozoite-stage infected RBCs (5 	 108 cells) were washed
three times in PBS, resuspended in 200-l water, and internal standards
were added [5 ng each of 5(6)-EET-d11, 8(9)-EET-d11, 11(12)-EET-d11,
14(15)-EET-d11, and 9(10)-EpOME-d4]. Phospholipids were extracted
twice using 2:1 CHCl3-CH3OHwith 0.1 mM triphenylphosphine, hydro-
lyzed using phospholipase A2, and extracted twice with ethyl acetate as
described previously (13). The dried extract was stored at 80°C until
analysis, when it was suspended in 100 l of methanol. After removing
particulates, 10 l of the supernatant were injected onto an online trap-
ping liquid chromatography coupled to tandem mass spectrometry (LC/
MS/MS) system. This system consists of a Leap PAL autosampler, four
Shimadzu high-performance liquid chromatography (HPLC) 20AD
pumps, and an API-4000 quadrupole mass spectrometer. Two types of
Thermo-Keystone C18 betasil trapping column (2 by 10 mm; 5 m) and
C18 betasil analytical column (2 by 100 mm; 3 m) were used for the
analyses. Themobile phases were 1% formic acid in water and acetonitrile
for the trapping column and 10 mM ammonium formate in water and
acetonitrile for the analytical column. Solvent gradient programs were
used for trapping and analytical runs. Negative ion multiple reaction
monitoring (MRM)modewas used to detect all analyte signals. For quan-
tification of all analytes, four point calibration standards of all analytes
were prepared in the presence of the deuterated internal standards and
were injected onto the system for calibration curves. Analyst 1.5.2 version
software was used for operation and quantification.
Statistical analyses.Data are expressed as means standard errors of
the means (SEMs). Statistical comparisons were made using a t test
(paired/unpaired as indicated), one-way analysis of variance (ANOVA)
with Tukey’s posttest. Statistical analyses were performed in GraphPad
Prism v 5.01.
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